Coya Therapeutics, Inc.

Filed a patent for "serum immune-based biomarkers for use in als therapy" on Thu, March 14, 2024

Filed a patent for "biomarkers of amyotrophic lateral sclerosis and uses thereof" on Tue, March 21, 2023

Filed a patent for "methods for producing regulatory t cell (treg) populations, treg compositions and methods for treatment" on Thu, December 7, 2023

Filed a patent for "methods and compositions for treatment of disease" on Thu, May 9, 2024